About
15+ years experience in Translational Immunobiology across various disease settings…
Activity
-
We are thrilled to announce #FDA clearance of #IND application for ALTA2618, the first mutant-selective targeted therapy for patients with AKT1…
We are thrilled to announce #FDA clearance of #IND application for ALTA2618, the first mutant-selective targeted therapy for patients with AKT1…
Liked by Heba Nowyhed
-
A few weeks after the official signing, Jeito Capital is delighted to share the successful closing of its portfolio company EyeBio by Merck &…
A few weeks after the official signing, Jeito Capital is delighted to share the successful closing of its portfolio company EyeBio by Merck &…
Liked by Heba Nowyhed
Experience
Education
Publications
-
the nuclear receptor nr4a1 controls cd8 t cell development through transcriptional suppression of runx3.
scientific reports
the nr4a nuclear receptor family member nr4a1 is strongly induced in thymocytes undergoing selection, and has been shown to control the development of treg cells; however the role of nr4a1 in cd8(+) t cells remains undefined. here we report a novel role for nr4a1 in regulating the development and frequency of cd8(+) t cells through direct transcriptional control of runx3. we discovered that nr4a1 recruits the corepressor, corest to suppress runx3 expression in cd8(+) t cells. loss of nr4a1…
the nr4a nuclear receptor family member nr4a1 is strongly induced in thymocytes undergoing selection, and has been shown to control the development of treg cells; however the role of nr4a1 in cd8(+) t cells remains undefined. here we report a novel role for nr4a1 in regulating the development and frequency of cd8(+) t cells through direct transcriptional control of runx3. we discovered that nr4a1 recruits the corepressor, corest to suppress runx3 expression in cd8(+) t cells. loss of nr4a1 results in increased runx3 expression in thymocytes which consequently causes a 2-fold increase in the frequency and total number of intrathymic and peripheral cd8(+) t cells. our findings establish nr4a1 as a novel and critical player in the regulation of cd8 t cell development through the direct suppression of runx3.
Other authorsSee publication -
B Cells in T Follicular Helper Cell Development and Function: Separable Roles in Delivery of ICOS Ligand and Antigen
Journal of Immunology
Abstract B cells are required for follicular Th (Tfh) cell development, as is the ICOS ligand
(ICOS-L); however, the separable contributions of Ag and ICOS-L delivery by cognate B
cells to Tfh cell development and function are unknown. We find that Tfh cell and germinal
center differentiation are dependent on cognate B cell display of ICOS-L, but only when Ag
presentation by the latter is limiting, with the requirement for B cell expression of ICOS-L
overcome by robust Ag…Abstract B cells are required for follicular Th (Tfh) cell development, as is the ICOS ligand
(ICOS-L); however, the separable contributions of Ag and ICOS-L delivery by cognate B
cells to Tfh cell development and function are unknown. We find that Tfh cell and germinal
center differentiation are dependent on cognate B cell display of ICOS-L, but only when Ag
presentation by the latter is limiting, with the requirement for B cell expression of ICOS-L
overcome by robust Ag delivery. These findings demonstrate that Ag-specific B cells ... -
NR4A nuclear receptors in immunity and atherosclerosis
Current Opinion in Lipidology
To understand chronic inflammatory diseases such as
atherosclerosis, we require in-depth knowledge on immune-cell differentiation, function of
specific immune-cell subsets and endothelial cell-mediated extravasation. In this review, we
summarize a number of very recent observations on the pivotal function of NR4A nuclear
receptors in immunity and atherosclerosis. -
ATP-Binding Cassette Transporter G1 Intrinsically Regulates Invariant NKT Cell Development.
Journal of Immunology
ATP-binding cassette transporter G1 (ABCG1) plays a role in the intracellular transport of cholesterol. Invariant NKT (iNKT) cells are a subpopulation of T lymphocytes that recognize glycolipid Ags. In this study, we demonstrate that ABCG1 regulates iNKT cell development and functions in a cell-intrinsic manner. Abcg1(-/-) mice displayed reduced frequencies of iNKT cells in thymus and periphery. Thymic iNKT cells deficient in ABCG1 had reduced membrane lipid raft content, and showed impaired…
ATP-binding cassette transporter G1 (ABCG1) plays a role in the intracellular transport of cholesterol. Invariant NKT (iNKT) cells are a subpopulation of T lymphocytes that recognize glycolipid Ags. In this study, we demonstrate that ABCG1 regulates iNKT cell development and functions in a cell-intrinsic manner. Abcg1(-/-) mice displayed reduced frequencies of iNKT cells in thymus and periphery. Thymic iNKT cells deficient in ABCG1 had reduced membrane lipid raft content, and showed impaired proliferation and defective maturation during the early stages of development. Moreover, we found that Abcg1(-/-) mice possess a higher frequency of Vβ7(+) iNKT cells, suggesting alterations in iNKT cell thymic selection. Furthermore, in response to CD3ε/CD28 stimulation, Abcg1(-/-) thymic iNKT cells showed reduced production of IL-4 but increased production of IFN-γ. Our results demonstrate that changes in intracellular cholesterol homeostasis by ABCG1 profoundly impact iNKT cell development and function.
-
The characterization of thymus-derived natural Th17 cells and their response to inflammation.
Journal of Immunology
CD4 T helper (Th) cells that secrete interleukin (IL)-17 (Th17) complement the function of
Th1 and Th2 cells as a third effector lineage, with a distinct role in neutrophil recruitment
necessary for extracellular pathogen clearance and the promotion of certain autoimmune
conditions. We have previously demonstrated that natural Th17 (nTh17) cells develop within
the thymus in a manner similar to that of natural T regulatory (nTreg) cells (Marks et al., Nat.
Immunol. 2009)…CD4 T helper (Th) cells that secrete interleukin (IL)-17 (Th17) complement the function of
Th1 and Th2 cells as a third effector lineage, with a distinct role in neutrophil recruitment
necessary for extracellular pathogen clearance and the promotion of certain autoimmune
conditions. We have previously demonstrated that natural Th17 (nTh17) cells develop within
the thymus in a manner similar to that of natural T regulatory (nTreg) cells (Marks et al., Nat.
Immunol. 2009), with activation in response to an increase of self-antigen due to tissue ... -
Development of a nanoparticulate formulation of retinoic acid that suppresses Th17 cells and upregulates regulatory T cells.
Self Nonself
Retinoic acid (RA) is a small molecule capable of shunting developing T cells away from the Th17 lineage and towards the Treg phenotype, making it a potentially useful therapeutic for autoimmune and inflammatory diseases. However, therapy can be complicated by systemic toxicity and unpredictable bioavailability, making a targeted drug delivery vehicle for local therapy desirable. A promising approach is the use of nanoparticles, which have been demonstrated to increase potency and decrease…
Retinoic acid (RA) is a small molecule capable of shunting developing T cells away from the Th17 lineage and towards the Treg phenotype, making it a potentially useful therapeutic for autoimmune and inflammatory diseases. However, therapy can be complicated by systemic toxicity and unpredictable bioavailability, making a targeted drug delivery vehicle for local therapy desirable. A promising approach is the use of nanoparticles, which have been demonstrated to increase potency and decrease toxicity of therapies in a variety of disease models including Th17 mediated diseases. Nanoparticles can also be targeted to specific cell types via surface modification, further increasing the potential specificity of this approach. We therefore constructed a nanoparticulate drug delivery platform from poly(lactic-co-glycolic acid) (PLGA) capable of encapsulating and releasing RA. Here we report the fabrication, characterization, and in vitro bioactivity of this platform. We demonstrate that RA containing PLGA nanoparticles suppress IL-17 production and ROR-γ(t) expression in T cells polarized towards the Th17 phenotype in vitro with similar potency to that of free drug. Furthermore, we show that these particles enhance TGF-β dependent Foxp3 expression and IL-10 production of T cells in vitro with similar potency to free RA. Finally, we demonstrate that T cells polarized towards the Th17 phenotype in the presence of free and nanoparticulate RA have similarly suppressed ability to induce IL-6 production by fibroblasts. Our findings demonstrate the feasibility of RA delivery via biodegradable nanoparticles and represent an exciting technology for the treatment of autoimmune and inflammatory diseases.
-
Thymic self-reactivity selects natural interleukin 17-producing T cells that can regulate peripheral inflammation.
Nature Immunology
Interleukin 17 (IL-17)-producing CD4(+) helper T cells (T(H)-17 cells) share a developmental relationship with Foxp3(+) regulatory T cells (T(reg) cells). Here we show that a T(H)-17 population differentiates in the thymus in a manner influenced by recognition of self antigen and by the cytokines IL-6 and transforming growth factor-beta (TGF-beta). Like previously described T(H)-17 cells, the T(H)-17 cells that developed in the thymus expressed the transcription factor RORgamma t and the IL-23…
Interleukin 17 (IL-17)-producing CD4(+) helper T cells (T(H)-17 cells) share a developmental relationship with Foxp3(+) regulatory T cells (T(reg) cells). Here we show that a T(H)-17 population differentiates in the thymus in a manner influenced by recognition of self antigen and by the cytokines IL-6 and transforming growth factor-beta (TGF-beta). Like previously described T(H)-17 cells, the T(H)-17 cells that developed in the thymus expressed the transcription factor RORgamma t and the IL-23 receptor. These cells also expressed alpha(4)beta(1) integrins and the chemokine receptor CCR6 and were recruited to the lung, gut and liver. In the liver, these cells secreted IL-22 in response to self antigen and mediated host protection during inflammation. Thus, T(H)-17 cells, like T(reg) cells, can be selected by self antigens in the thymus.
Honors & Awards
-
NIH F32 Ruth L. Kirschstein National Research Service Award (NRSA)
National Institute of Health
Postdoctoral Fellowship Award
Languages
-
English
Full professional proficiency
-
Arabic
Limited working proficiency
More activity by Heba
-
Insight Partners is proud to support Autobahn in their mission to address unmet needs in depression and other neuropsychiatric conditions.
Insight Partners is proud to support Autobahn in their mission to address unmet needs in depression and other neuropsychiatric conditions.
Liked by Heba Nowyhed
-
With 125+ clients worldwide, 200+ pre-clinical/CMC and clinical #immunogenicity studies under our belts, and a team of 10 PhD, 8 MSc, and 7 BSc…
With 125+ clients worldwide, 200+ pre-clinical/CMC and clinical #immunogenicity studies under our belts, and a team of 10 PhD, 8 MSc, and 7 BSc…
Liked by Heba Nowyhed
-
Delighted to announce the unveiling of our latest company creation with the (very oversubscribed) $165M Series A of Third Arc Bio. Opening credits:…
Delighted to announce the unveiling of our latest company creation with the (very oversubscribed) $165M Series A of Third Arc Bio. Opening credits:…
Liked by Heba Nowyhed
-
Third Arc Bio, a preclinical company developing multifunctional antibodies optimized for best-in-class T cell modulation across #solidtumors and #I&I…
Third Arc Bio, a preclinical company developing multifunctional antibodies optimized for best-in-class T cell modulation across #solidtumors and #I&I…
Liked by Heba Nowyhed
-
Exciting news, congratulations to Paul Grayson, Brett Ewald, R Scott Struthers, Radionetics Oncology, Eli Lilly and Company, and GordonMD® Global…
Exciting news, congratulations to Paul Grayson, Brett Ewald, R Scott Struthers, Radionetics Oncology, Eli Lilly and Company, and GordonMD® Global…
Liked by Heba Nowyhed
-
CAR-Ts sweep into autoimmunity Good article in Nature Biotechnology providing an overview of the biotech landscape focusing on CAR-T cells to target…
CAR-Ts sweep into autoimmunity Good article in Nature Biotechnology providing an overview of the biotech landscape focusing on CAR-T cells to target…
Liked by Heba Nowyhed
-
Today, we announced the successful dosing of our first #allogeneic #Tr1 #Treg cell therapy candidate, TRX103, in #GvHD prevention for patients…
Today, we announced the successful dosing of our first #allogeneic #Tr1 #Treg cell therapy candidate, TRX103, in #GvHD prevention for patients…
Liked by Heba Nowyhed
-
The Immunology Center of Georgia (IMMCG) has established the Margaret-Gertraud Immunology Lectureship, funded by the center’s founding co-directors…
The Immunology Center of Georgia (IMMCG) has established the Margaret-Gertraud Immunology Lectureship, funded by the center’s founding co-directors…
Liked by Heba Nowyhed
-
Great work on IBD research from La Jolla Institute for Immunology, Yingcong Li Mitchell Kronenberg Pandurangan "Vijay" Vijayanand
Great work on IBD research from La Jolla Institute for Immunology, Yingcong Li Mitchell Kronenberg Pandurangan "Vijay" Vijayanand
Liked by Heba Nowyhed
-
So proud of our teams and the willingness to tackle the norm and do what’s necessary to change the lives of patients.
So proud of our teams and the willingness to tackle the norm and do what’s necessary to change the lives of patients.
Liked by Heba Nowyhed
-
Proud to co-lead InduPro’s $85 million Series A financing as they leverage induced proximity to modulate disease biology towards next-generation…
Proud to co-lead InduPro’s $85 million Series A financing as they leverage induced proximity to modulate disease biology towards next-generation…
Liked by Heba Nowyhed
-
Happening TODAY!! Come on out to the Festival of Genomics & Biodata and let's talk about the next generation of biomarkers. I'll be on stage in the…
Happening TODAY!! Come on out to the Festival of Genomics & Biodata and let's talk about the next generation of biomarkers. I'll be on stage in the…
Liked by Heba Nowyhed
-
Little knowledge of medicine is more dangerous than no knowledge at all. The last thing cancer patients and caregivers need is misinformation and…
Little knowledge of medicine is more dangerous than no knowledge at all. The last thing cancer patients and caregivers need is misinformation and…
Liked by Heba Nowyhed
Other similar profiles
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore More